首页> 美国卫生研究院文献>High-Throughput >The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders
【2h】

The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders

机译:Cytoscan HD阵列在神经发育障碍的诊断中

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Submicroscopic chromosomal copy number variations (CNVs), such as deletions and duplications, account for about 15–20% of patients affected with developmental delay, intellectual disability, multiple congenital anomalies, and autism spectrum disorder. Most of CNVs are de novo or inherited rearrangements with clinical relevance, but there are also rare inherited imbalances with unknown significance that make difficult the clinical management and genetic counselling. Chromosomal microarrays analysis (CMA) are recognized as the first-line test for CNV detection and are now routinely used in the clinical diagnostic laboratory. The recent use of CMA platforms that combine classic copy number analysis with single-nucleotide polymorphism (SNP) genotyping has increased the diagnostic yields. Here we discuss the application of the Cytoscan high-density (HD) SNP-array for the detection of CNVs. We provide an overview of molecular analyses involved in identifying pathogenic CNVs and highlight important guidelines to establish pathogenicity of CNV.
机译:亚显微染色体拷贝数变异(CNV),例如缺失和重复,约占发育迟缓,智力障碍,多发性先天性异常和自闭症谱系障碍患者的15-20%。大部分CNV是从头发生的或具有临床相关性的遗传重排,但也有罕见的遗传失衡,其意义不明,使临床管理和遗传咨询变得困难。染色体微阵列分析(CMA)是公认的CNV检测的一线检测方法,目前已在临床诊断实验室中常规使用。 CMA平台最近的使用将经典的拷贝数分析与单核苷酸多态性(SNP)基因型相结合,提高了诊断率。在这里,我们讨论Cytoscan高密度(HD)SNP阵列在CNV检测中的应用。我们提供了涉及识别致病性CNV的分子分析的概述,并重点介绍了建立CNV致病性的重要指导原则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号